$ELVR

Elevra Lithium Signs Spodumene Supply Agreement with LG Energy Solution

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) signed a 3-year spodumene supply deal with LG Energy Solution, starting in 2026. The agreement covers 240,000 dmt, with optional volumes up to 90,000 dmt. Pricing is market-linked. Elevra aims to diversify its sales portfolio and secure strategic customers for its North American Lithium operations.

Original reporting
Published Oct 8, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 1:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ELVR
Bullish
high confidence
Mentioned
$ELVR
Relevance
7/10
AlphAI data visualization · based on globenewswire.com
Decision brief

The 30-second read

$ELVRBullishMed
01

Why it matters

The agreement secures a multi‑year offtake, reducing revenue volatility for Elevra and potentially improving its valuation.

02

Market read

First disclosure of a sizable long‑term supply contract for a junior lithium producer, likely to influence its share price.

03

What to watch

Potential execution risk at the Quebec mine and LG Energy Solution's own demand outlook.

Relevance 7/10Novelty 7/10Timing: today

Background

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) is a junior lithium producer developing the North American Lithium project in Quebec. LG Energy Solution is a major global battery manufacturer.

Company-level read

Ticker impact

$ELVRBullishHigh confidence
Context

Elevra Lithium announced a binding three‑year spodumene concentrate supply agreement with LG Energy Solution for up to 240,000 dmt, securing a major customer for its North American Lithium project.

Expected impact

upside pressure as investors price in the new long‑term offtake deal

Evidence & confidence

First‑report supply agreement with a leading battery maker reduces demand uncertainty and may lift the stock on the news.

Market effects

Strengthens the North American lithium supply chain and may boost sentiment for other lithium producers.

Highlights growing demand for battery‑grade spodumene in North America.

Supports broader EV battery material supply dynamics.

Counterpoint

If market pricing for spodumene falls, the market‑linked pricing could limit upside.

Key entities

  • Elevra Lithium Limited

    North American lithium producer announcing the supply deal.

  • LG Energy Solution

    Battery manufacturer entering into the offtake agreement.

Related articles

$ELVRMedAI 8/10

Elevra Lithium Provides Ewoyaa Sale Update

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) updates on the sale of its Ewoyaa Lithium Project to Zhejiang Huayou Cobalt. The deal, valued at ~$71M, awaits Ghanaian government approval. If not secured by Oct 30, 2026, Huayou can pay a $5M break fee or terminate. Huayou also received FIRB approval for its acquisition of Atlantic Lithium, which holds the remaining private-sector interest in Ewoyaa.

$ELVRMedAI 8/10

Elevra fires up NAL lithium mine expansion

Elevra Lithium (ASX: ELV, Nasdaq: ELVR) has begun a $366M expansion of its North American Lithium mine in Quebec, aiming to nearly double production to 373,000 tonnes of spodumene concentrate by 2029. The project, funded by equity and convertible notes, is expected to reduce costs and secure customers through price-protected offtake agreements, including a deal with Mangrove Lithium.

$ELVRMed

Elevra Lithium Announces NAL Expansion Pre-Feasibility Study

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) announced a Pre-Feasibility Study for its North American Lithium (NAL) expansion in Québec. The study projects increased annual spodumene concentrate production to 373ktpa, reduced unit costs, and a post-tax NPV of C$3,218M. The expansion is fully funded with C$366M in initial CAPEX and will be delivered in three stages, starting mid-2027.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Corporate Presentation - Outlines Growth Strategy for North American Lithium Platform

Elevra Lithium Ltd (ASX:ELV) outlined its growth strategy for North American Lithium (NAL) in Quebec, targeting 373,000 tonnes of spodumene concentrate annually. FY26 production was 197,967 tonnes, with revenue of US$202 million. The company plans a three-stage expansion, with initial capital expenditure of US$271 million. FY27 production guidance is 198,000 to 210,000 tonnes.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) NAL Expansion Pre-Feasibility Study

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) announced a Pre-Feasibility Study for its North American Lithium (NAL) expansion, targeting increased spodumene production and reduced costs. The project, fully funded at C$366M, aims to boost annual output to 373ktpa by mid-2029, with a post-tax NPV of C$3.218B. The expansion is expected to reduce LOM C1 costs to C$851/t post-expansion, according to the company.